36
Participants
Start Date
October 31, 2012
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Laboratory Biomarker Analysis
Correlative studies
Pharmacological Study
Correlative studies
Tivantinib
Given PO
Columbia University Medical Center, New York
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Children's National Medical Center, Washington D.C.
Children's Healthcare of Atlanta - Egleston, Atlanta
Children's Hospital of Alabama, Birmingham
St. Jude Children's Research Hospital, Memphis
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children, Indianapolis
C S Mott Children's Hospital, Ann Arbor
Midwest Children's Cancer Center, Milwaukee
University of Minnesota Medical Center-Fairview, Minneapolis
Lurie Children's Hospital-Chicago, Chicago
Washington University School of Medicine, St Louis
Baylor College of Medicine, Houston
Childrens Hospital of Orange County, Orange
UCSF Medical Center-Parnassus, San Francisco
Oregon Health and Science University, Portland
Seattle Children's Hospital, Seattle
Hospital for Sick Children, Toronto
National Cancer Institute (NCI)
NIH